Heesen, P.; Di Lonardo, M.; Ciobanu-Caraus, O.; Schelling, G.; Zwahlen, D.; Bode-Lesniewska, B.; Glanzmann, C.; Studer, G.; Fuchs, B., on behalf of the Swiss Sarcoma Network.
Ultrahypofractionated Versus Normofractionated Preoperative Radiotherapy for Soft Tissue Sarcoma: A Multicenter, Prospective Real-World-Time Phase 2 Clinical Trial. Cancers 2024, 16, 4063.
https://doi.org/10.3390/cancers16234063
AMA Style
Heesen P, Di Lonardo M, Ciobanu-Caraus O, Schelling G, Zwahlen D, Bode-Lesniewska B, Glanzmann C, Studer G, Fuchs B on behalf of the Swiss Sarcoma Network.
Ultrahypofractionated Versus Normofractionated Preoperative Radiotherapy for Soft Tissue Sarcoma: A Multicenter, Prospective Real-World-Time Phase 2 Clinical Trial. Cancers. 2024; 16(23):4063.
https://doi.org/10.3390/cancers16234063
Chicago/Turabian Style
Heesen, Philip, Michele Di Lonardo, Olga Ciobanu-Caraus, Georg Schelling, Daniel Zwahlen, Beata Bode-Lesniewska, Christoph Glanzmann, Gabriela Studer, and Bruno Fuchs on behalf of the Swiss Sarcoma Network.
2024. "Ultrahypofractionated Versus Normofractionated Preoperative Radiotherapy for Soft Tissue Sarcoma: A Multicenter, Prospective Real-World-Time Phase 2 Clinical Trial" Cancers 16, no. 23: 4063.
https://doi.org/10.3390/cancers16234063
APA Style
Heesen, P., Di Lonardo, M., Ciobanu-Caraus, O., Schelling, G., Zwahlen, D., Bode-Lesniewska, B., Glanzmann, C., Studer, G., & Fuchs, B., on behalf of the Swiss Sarcoma Network.
(2024). Ultrahypofractionated Versus Normofractionated Preoperative Radiotherapy for Soft Tissue Sarcoma: A Multicenter, Prospective Real-World-Time Phase 2 Clinical Trial. Cancers, 16(23), 4063.
https://doi.org/10.3390/cancers16234063
